In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
7 authors.
Aashka K PopatUCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Rhiana C SimonUCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0001-6672-3816 Beatriz B AoyamaUCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0003-1458-5516 Ahana WokhluUCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Aliza T EhrlichUCSF Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.ORCID 0000-0001-7507-1100 Corey C HarwellUCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0002-8043-5869 Elyssa B MargolisUCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0001-8777-302X Funding
The impact of early life opioid exposure on the molecular and functional trajectories of septal cell typesR01DA059388 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COREY C HARWELL, Garret D Stuber · 2023 to 2026
$3.1MTemporal Specification of Basal Forebrain CircuitryR37MH119156 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COREY C HARWELL · 2024 to 2026
$2.1MDirect lateral habenula projection to a critical pain transmission circuitR01NS134981 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Elyssa Margolis · 2024 to 2026
$1.9MThe role of the VTA-lateral habenula circuit in opioid mediated behaviorsR01DA042025 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARGOLIS, ELYSSA · 2017 to 2021
$1.8MNeuronal Gαi-GPCR targeting to primary cilia and impact on cAMP mediated transcriptionK01MH123757 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EHRLICH, ALIZA TOBY · 2020 to 2024
$792kNIDA NIH HHS R01 DA042025NIDA NIH HHS R01 DA059388NIMH NIH HHS K01 MH123757NIMH NIH HHS R37 MH119156NINDS NIH HHS R01 NS134981
6 · The paper itselfAbstract
The habenula (Hb), which contains medial and lateral subdivisions (MHb and LHb, respectively), has high intensity mu opioid binding and receptor (MOR) expression, yet the details of MOR localization across these regions remains debated. MHb and LHb participate in largely non-overlapping neural circuits, therefore accurately resolving MOR expression across MHb and LHb is critical for understanding how MOR ligands impact behaviors. Here we utilized
Indexed as
addictionepithalamushabenulaopioid receptorOprm1painwithdrawal
Identifiers
PMID41446124
PMCPMC12724406
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390